Patient-Based Pricing: An Answer To The Soaring Cost of Innovation?

Posted by on Sep 21, 2012 in Company, Cost/Comparative Effectiveness, Health Technology Assessments, Medical Innovation, Payers: Commercial, Payment Reform, Personalized Medicine, Pharmaceuticals, Pricing, Uncategorized, Value-based pricing

Roche’s investor day on Sept. 5 provided heartening news for breast cancer patients. Executives outlined an array of increasingly targeted therapeutic permutations to combat the tumor, building on its...

Learn More